Pulse nav.journalClub Debates ativos Tendências Explorar Pesquisadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidade

Início Explorar nav.journalClub Tendências

⌘+K

The discovery and development of HMG-CoA reductase inhibitors. | Synapse

November 1, 1992Open Access

The discovery and development of HMG-CoA reductase inhibitors.

Key Points

Key points are not available for this paper at this time.

Abstract

During the 1950s and 1960s, many cholesterol-lowering agents were reported and introduced into clinical use, in-

Read Full Paperexternally

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Akira Endo (Sun,) studied this question.

synapsesocial.com/papers/696d596d759b0975673779f0 https://doi.org/https://doi.org/10.1016/s0022-2275(20)41379-3

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cataracts in Patients Treated with Triparanol1962 · 101 citations
2Modification of Metabolism and Distribution of Lipids by Ethyl Chlorophenoxyisobutyrate1962 · 340 citations
3Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia1986 · 52 citations
4The Biosynthesis of Mevalonic Acid from 1-C14-Acetate by a Rat Liver Enzyme System1959 · 62 citations
5Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity1976 · 802 citations